Do the etiological factors in artificial urinary sphincter reimplantation cases affect success and complications?

Do the etiological factors in artificial urinary sphincter reimplantation cases affect success and complications?

Background/aim: The artificial urinary sphincter (AUS) is still one of the best options for incontinence treatment. It may also have anadvantage for revision or reimplantation in the management of complications. In this study we aimed to discuss the etiological factorsfor AUS reimplantation and effects of these etiological factors on success rates, patient satisfaction rates, time to reimplantation surgery,and complications.Materials and methods: Data from 30 patients for whom AUS reimplantation was performed were analyzed retrospectively. Incontinencedue to fluid loss from the cuff or reservoir balloon, inability of the cuff to adequately compress the urethra, and devices that were thoughtto have completed their lifespans were defined as mechanical reasons while incontinence caused by conditions such as cuff erosion andinfection were defined as nonmechanical reasons. Patients who went through reimplantation due to mechanical and nonmechanicalcauses were included in Group 1 and Group 2, respectively. Success rates, patient satisfaction rates, time between the implantation of thefirst and second AUS, and complications were compared between the groups.Results: The mean follow-up period was 79 (3–308) months for patients who went through primary AUS implantation due topostprostatectomy incontinence. Our success rates were found as 75% and 66% in Group 1 and Group 2, respectively. The differencesbetween the groups in terms of success and patient satisfaction rates were not statistically significant, while the time to reimplantationwas longer in Group 1 and statistically significant.Conclusion: Reasons for AUS reimplantation may affect the success and patient satisfaction rates. Our success rates of AUS performedfor nonmechanical reasons were slightly lower, but not statistically significantly so. AUS reimplantation may take a longer time ifmechanical failure is detected.

___

  • Shamliyan TA, Wyman JF, Ping R, Wilt TJ, Kane RL. Male urinary incontinence: prevalence, risk factors, and preventive interventions. Rev Urol 2009; 11: 145-165.
  • Thom D. Variation in estimates of urinary incontinence prevalence in the community: effects of differences in definition, population characteristics, and study type. J Am Geriatr Soc 1998; 46: 473-480.
  • Nitti VW. The prevalence of urinary incontinence. Rev Urol 2001; 3: 2-6.
  • Lucas MG, Bedretdinova D, Bosch JLHR, Burkhard F, Cruz F, Nambiar AK, Nilsson CG, de Ridder DJMK, Tubaro A, Pickard RS et al. Guidelines on Urinary Incontinence. European Society for Urinary Incontinence. Arnhem, the Netherlands: European Association of Urology; 2014.
  • Porena M, Mearini E, Mearini L, Vianello A, Giannantoni A. Voiding dysfunction after radical retropubic prostatectomy: more than external urethral sphincter deficiency. Eur Urol 2007; 52: 38-45.
  • Loughlin KR, Prasad MM. Post-prostatectomy urinary incontinence: a confluence of 3 factors. J Urol 2010; 183: 871- 877.
  • Kundu SD, Roehl KA, Eggener SE, Antenor JA, Han M, Catalona WJ. Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies. J Urol 2004; 172: 2227-2231.
  • Trigo Rocha F, Gomes CM, Mitre AL, Arap S, Srougi M. A prospective study evaluating the efficacy of the artificial sphincter AMS 800 for the treatment of postradical prostatectomy urinary incontinence and the correlation between preoperative urodynamic and surgical outcomes. Urology 2008; 71: 85-89.
  • Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30.
  • Cooperberg MR, Broering JM, Litwin MS, Lubeck DP, Mehta SS, Henning JM, Carroll PR. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry. J Urol 2004; 171: 1393-1401.
  • Hu JC, Elkin EP, Pasta DJ, Lubeck DP, Kattan MW, Carroll PR, Litwin MS. Predicting quality of life after radical prostatectomy: results from CapSURE. J Urol 2004; 171: 703-708.
  • Singla N, Singla AK. Post-prostatectomy incontinence: etiology, evaluation, and management. Turkish Journal of Urology 2014; 40: 1-8.
  • Kim SP, Sarmast Z, Daignault S, Faerber GJ, McGuire EJ, Latini JM. Long-term durability and functional outcomes among patients with artificial urinary sphincters: a 10 years retrospective review from the University of Michigan. J Urol 2008; 179: 1912-1916.
  • Venn SN, Greenwell TJ, Mundy AR. The long-term outcome of artificial urinary sphincters. J Urol 2000; 164: 702-706.
  • Hajivassiliou CA. A review of the complications and results of implantation of the AMS artificial urinary sphincter. Eur Urol 1999; 35: 36-44.
  • Clemens JQ, Schuster TG, Konnak JW, McGuire EJ, Faerber GJ. Revision rate after artificial urinary sphincter implantation for incontinence after radical prostatectomy: actuarial analysis. J Urol 2001; 166: 1372-1375.
  • James MH, McCammon KA. Artificial urinary sphincter for post-prostatectomy incontinence: a review. Int J Urol 2014; 21: 536-543.
  • Anusionwu II, Wright EJ. Indications for revision of artifıcial urinary sphincter and modifiable risk factors for device-related morbidity. Neurourol Urodyn 2013; 32: 63-65.
  • Raj GV, Peterson AC, Toh KL, Webster GW. Outcomes following revisions and secondary implantation of the artificial urinary sphincter. J Urol 2005; 173: 1242-1245.
  • Tuygun C, Imamoglu A, Gucuk A, Goktug G, Demirel F. Comparison of outcomes for adjustable bulbourethral male sling and artificial urinary sphincter after previous artificial urinary sphincter erosion. Urology 2009; 73: 1363-1370.
  • Shen YC, Chiang PH. The experience of artificial urinary sphincter implantation by a single surgeon in 15 years. Kaohsiung J Med Sci 2013; 29: 157-160.
  • Bugeja S, Ivaz SL, Frost A, Andrich DE, Mundy AR. Urethral atrophy after implantation of an artificial urinary sphincter: fact or fiction? BJU Int 2016; 117: 669-676.
  • Wang R, McGuire EJ, He C, Faerber GJ, Latini JM. Long-term outcomes after primary failures of artificial urinary sphincter ımplantation. Urology 2012; 79: 922-928.
  • Linder BJ, Cogain M, Elliott DS. Long-term device outcomes of artificial urinary sphincter reimplantation following prior explanation for erosion or ınfection. J Urol 2014; 191: 734-738.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Hatice ALGAN KAYA, Oğuz EROĞLU, Nesimi GÜNAL, Figen ÇOŞKUN, Turgut DENİZ

Ahmet ARNAZ, Ayla OKTAY, Serdar AKANSEL, Dilek ALTUN, Abdullah DOĞAN, Piotr SERBAN, Arda SAYGILI, Yusuf YALÇINBAŞ, Ayşe SARIOĞLU, Tayyar SARIOĞLU

Diagnostic value of ultrasonography in peroneal neuropathy

Ayşe OYTUN BAYRAK, İlkay Koray BAYRAK, Çetin Kürşad AKPINAR, Hande TÜRKER, Necdet BOLAT

Elif BOZÇAL DAĞDEVİREN

Ragıp ERTAŞ, Kemal ÖZYURT, Çiğdem KARAKÜKÇÜ, Muhammet Reşat AKKUŞ, Emin ÖZLÜ, Atıl AVCI, Mustafa ATASOY

Is 72 h of antimicrobial prophylaxis better than 24 h in elective gastric cancer surgery?

Xiang XIA, Gang ZHAO, Fengrong YU, Wei LING

Investigation of the effect of combined use of alloplastic-based tricalcium phosphate bone graft and antihemorrhagic plant extract (ABS) on bone regeneration in surgically induced bone defects in nondiabetic rats: an experimental animal study

Mehmet GÜL, Filiz ACUN KAYA, Engin DEVECİ, Abdulsamet TANIK, Sevgi İRTEGÜN KANDEMİR, Veysi AKPOLAT, Arzum Güler DOĞRU, Ebru SARIBAŞ

İşın AKYAR, Cengiz ÇAVUŞOĞLU, Meltem AYAŞ, Süheyla SÜRÜCÜOĞLU, Arzu İLKİ, Deniz Ece KAYA, Yeşim BEŞLİ

The role of soluble urokinase plasminogen activator receptor (SuPAR) as an indicator of the severity of acute pancreatitis

İbrahim KILINÇ, Adnan KARAİBRAHİMOĞLU, Başar CANDER, Sedat KOÇAK, Alpay TUNCAR, Mehmet ERGİN, Mehmet GÜL, Zerrin Defne DÜNDAR, Tamer ÇOLAK, Abdullah Sadık GİRİŞGİN, Kadir KÜÇÜKCERAN

Ufuk İLGEN, Gökhan NERGİZOĞLU